David Nau - Ph.D.

David Nau, Ph.D., is associate professor in the UK College of Pharmacy Department of Pharmacy Practice and Science. Previously, he held faculty appointments at the University of Michigan and West Virginia University. He received his B.S. in pharmacy from Ohio Northern University and an M.S. in pharmacy administration from the University of Toledo. Dr. Nau completed a pharmacy residency program at the Toledo Hospital and a specialized residency in hospital pharmacy management at Shands Hospital at the University of Florida. He worked in community pharmacy and hospital pharmacy management before receiving a Ph.D. in pharmacy administration from the University of Florida in 1997.

Dr. Nau's work has focused on the improvement of medication-use within the health care system. This has included evaluating the quality of medication-use for managed care enrollees with chronic diseases, the establishment of pharmacy-based disease management programs, and the development of quality improvement systems for pharmacy services. He has conducted research on the causes and consequences of medication non-adherence and he helped to develop methodological standards for medication-adherence research for the International Society of Pharmacoeconomics and Outcomes Research. Dr. Nau frequently is an invited speaker on issues related to quality improvement and medication adherence, and he has served as a consultant to retail pharmacies, managed care organizations, and pharmacy regulatory boards.

Selected Publications/Presentations

• Nau DP. "Measuring the Quality of the Medication-Use System" In: Safe and Effective, (N. MacKinnon, editor). Canadian Pharmacists Association: Ottawa, CA; 2007.
• Nau DP, Kirking DM. "Why is Medication Use Less Than Appropriate?" In: Pharmaceutical Policy. (T. Fulda, editor). Haworth Press: New York; 2007.
• Nau DP, Chi C, Mallya U, Kirking DM. "Member Satisfaction Related to Self-Reported Cost Share and Difficulty in Obtaining Prescription Drugs in a University Pharmacy Benefit Plan." Journal of Managed Care Pharmacy 2007;13:135-41.
• Nau DP, Ellis JJ, Kline-Rogers EM, Mallya U, Eagle KA, Erickson SR. "Gender and Perceived Severity of Heart Disease: Evidence that Women are Tougher." American Journal of Medicine 2005;118:1256-61.
• Nau DP, Chao JD, Aikens JE. "The Relationship Between Guideline-Concordant Depression Treatment and Patient Adherence to Oral Diabetes Medications" Research in Social and Administrative Pharmacy 2005;1:378-88.
• Nau DP, Erickson SR. "Medication Safety: Patients' Experiences, Beliefs and Behaviors." Journal of the American Pharmacists Association 2005;45:452-57.
• Lau DT, Nau DP. "Oral Antihyperglycemic Medication Non-Adherence and Subsequent Hospitalization among Persons with Type 2 Diabetes." Diabetes Care 2004;27:2149-2153.
• Garber MA, Nau DP, Erickson SR, Aikens JE, Lawrence JB. "The Concordance of Self-Report with Other Measures of Medication Adherence: A Summary of the Literature." Medical Care 2004;42:649-652.
• Nau DP, Garber MA, Lipowski EE, Stevenson J. "Quality Improvement for Pharmacy Services and Its Relationship to Hospital Size." American Journal of Health-Systems Pharmacy 2004;61:184-9.
• Pickard AS, Nau DP, McKercher P, Schumock GT. The Importation of Prescription Medications: What are Pharmacists Experiences, Opinions and Intended Behaviors? Journal of the American Pharmacists Association 2004;44:666-72
• Nau DP, Garber MA, Herman WH. "The Intensification of Drug Therapy for Diabetes and Its' Complications: Evidence from Two HMOs." American Journal of Managed Care 2004;10:118-123.
• Nau DP, Kumar R. "The Relationship of Diabetes Mellitus Performance Indicators with Self-Reported Health and Patient Satisfaction." Disease Management & Health Outcomes 2002;10:707-13.
• Nau DP. "Evaluating Medication Use for Continuous Quality Improvement in Diabetes Care." Journal of Managed Care Pharmacy 2002;8:378-82.